investors can Contact the law firm for free to learn more about recovering their losses

LOS ANGELES, Oct. 27, 2022 (GLOBE NEWSWIRE) — The law firm of Portnoy is informing investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or “the Company”) (NASDAQ: YMAB) that the Company has opened an investigation into possible securities fraud and may file a class action lawsuit on behalf of the investors. Y-mAbs investors who have lost money investing are encouraged to do so Contact Lesley Portnoy, Esq.

Investors are encouraged to contact an attorney Lesley F Portnoyby phone 844-767-8529 or E-mail: [email protected] to discuss your legal rights, or click here to join the case about www.portnoylaw.com. Portnoy Law Firm can provide a free case assessment and discuss investors’ options for making claims to recover their losses.

The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose information relevant to investors. Y-mAbs is the subject of briefing documents posted on the FDA website on October 26, 2022. According to the documents, FDA scientists have raised concerns about the data submitted as part of the company’s Biologics License Application (BLA) for omburtamab. The FDA identified several issues with the company’s data, including differences between the study and control populations. Based on this news, shares of Y-mAbs fell more than 23% in intraday trading on the same day.

Please visit our website to verify further information and to submit your transaction information.

Portnoy Law Firm represents investors in asserting claims against companies caused by wrongdoing. The firm’s founding partner has recovered over $5.5 billion for aggrieved investors. attorney advertising. Previous results do not guarantee similar results.

Lesley F. Portnoy, Esq.
Bar Association in CA and NY
[email protected]
310-692-8883
www.portnoylaw.com
lawyer advertising